Seeing Is Believing
Currently out of the existing stock ratings of Gbola Amusa, 21 are a HOLD (19.81%), 75 are a BUY (70.75%), 10 are a SELL (9.43%).
Analyst Gbola Amusa works at CHARDAN CAPITAL with a stock forecast success ratio of 66.97% fulfilled within 293.64 days on average.
Gbola Amusa’s has documented 212 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on PASG, Passage Bio at 07-Aug-2023.
Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES LLC).
The best stock recommendation documented was for SLDB (SOLID BIOSCIENCES LLC) at 6/25/2018. The price target of $562.5 was fulfilled within 2 days with a profit of $84.75 (13.09%) receiving and performance score of 65.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22
$12 (120.00%)
4
4 days ago
4/5 (80%)
$12.81 (139.39%)
279
Buy
6
$4.05 (207.69%)
4
7 months 28 days ago
4/7 (57.14%)
$4.22 (237.08%)
196
Buy
4
$-6 (-60.00%)
2
8 months 22 days ago
4/4 (100%)
$2.11 (111.64%)
432
Hold
3
$-7 (-70.00%)
6
1 years 5 months 22 days ago
3/4 (75%)
$2.23 (289.61%)
528
Hold
2
$-8 (-80.00%)
5
2 years 9 months 10 days ago
3/3 (100%)
$-0.36 (-15.25%)
397
What Year was the first public recommendation made by Gbola Amusa?